133 related articles for article (PubMed ID: 11991536)
1. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction.
Grobosch T; Lemm-Ahlers U
J Anal Toxicol; 2002 Apr; 26(3):181-6. PubMed ID: 11991536
[TBL] [Abstract][Full Text] [Related]
2. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
Verstraete AG; Steyaert S
J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
[TBL] [Abstract][Full Text] [Related]
4. False-positive LSD testing in urine samples from intensive care patients.
Röhrich J; Zörntlein S; Lotz J; Becker J; Kern T; Rittner C
J Anal Toxicol; 1998 Sep; 22(5):393-5. PubMed ID: 9737335
[TBL] [Abstract][Full Text] [Related]
5. Analysis of LSD in human body fluids and hair samples applying ImmunElute columns.
Röhrich J; Zörntlein S; Becker J
Forensic Sci Int; 2000 Jan; 107(1-3):181-90. PubMed ID: 10689571
[TBL] [Abstract][Full Text] [Related]
6. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
[TBL] [Abstract][Full Text] [Related]
7. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
Schwettmann L; Külpmann WR; Vidal C
Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
[TBL] [Abstract][Full Text] [Related]
8. LSD screening in urine performed by CEDIA® LSD assay: positive interference with sertraline.
Citterio-Quentin A; Seidel E; Ramuz L; Parant F; Moulsma M
J Anal Toxicol; 2012 May; 36(4):289-90. PubMed ID: 22511703
[No Abstract] [Full Text] [Related]
9. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure.
Webb KS; Baker PB; Cassells NP; Francis JM; Johnston DE; Lancaster SL; Minty PS; Reed GD; White SA
J Forensic Sci; 1996 Nov; 41(6):938-46. PubMed ID: 8914284
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of LSD intoxication by analysis of serum and urine.
McCarron MM; Walberg CB; Baselt RC
J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406
[TBL] [Abstract][Full Text] [Related]
11. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
Vu-Duc T; Vernay A; Calanca A
Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150
[TBL] [Abstract][Full Text] [Related]
12. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
Burnley BT; George S
J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
[TBL] [Abstract][Full Text] [Related]
13. False-positive LSD drug screening induced by a mucolytic medication.
Lotz J; Hafner G; Röhrich J; Zörntlein S; Kern T; Prellwitz W
Clin Chem; 1998 Jul; 44(7):1580-1. PubMed ID: 9665451
[No Abstract] [Full Text] [Related]
14. Interference with testing for lysergic acid diethylamide.
Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
Cassells NP; Craston DH; Hand CW; Baldwin D
J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
[TBL] [Abstract][Full Text] [Related]
16. Stability study of LSD under various storage conditions.
Li Z; McNally AJ; Wang H; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):520-5. PubMed ID: 9788528
[TBL] [Abstract][Full Text] [Related]
17. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.
Klette KL; Horn CK; Stout PR; Anderson CJ
J Anal Toxicol; 2002; 26(4):193-200. PubMed ID: 12054358
[TBL] [Abstract][Full Text] [Related]
18. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
[TBL] [Abstract][Full Text] [Related]
19. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
Mardal M; Johansen SS; Thomsen R; Linnet K
Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
[TBL] [Abstract][Full Text] [Related]
20. Immunoassay analysis of lysergic acid diethylamide.
Cody JT; Valtier S
J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
